We are excited to announce that PDCI Market Access Inc. (“PDCI”) has entered into an Exclusive License Agreement for the ... Read More
News
31
Mar2020
26
Mar2020
Government Authorizes Temporary Compulsory Liscensing in Emergency Legislation for Products Needed to Respond to the COVID-19 Emergency
/ News
Bill C-13 is the government’s emergency legislation in response to the COVID-19 pandemic. The bill includes amendments to the ... Read More
19
Mar2020
PMPRB Has Now Published Submissions Received as Part of its Draft Guidelines Consultation
/ PDCI, PMPRB, What's New
The full list of submissions can be found here under the Submissions tab at the bottom of ... Read More
16
Mar2020
Good Afternoon,
At PDCI Market Access Inc. (“PDCI”) we are committed to providing high quality services and deliverables to our clients. ... Read More
10
Mar2020
PMPRB Cancellation of March 18th Policy Forum
The Patented Medicines Prices Review Board (PMPRB) has announced the ... Read More
25
Feb2020
Sharing Responses to the Patented Medicine Prices Review Board (PMPRB) Draft Guidelines Consultation
On November 21, 2019, the PMPRB published its draft Guidelines and launched a public consultation as a step towards implementing ... Read More
24
Feb2020
Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of ... Read More
14
Feb2020
CADTH’s Pharmaceutical Reviews Updates are used to communicate new CDR and pCODR drug review process updates to the public. PDCI ... Read More